» Journals » Bull Cancer

Bulletin Du Cancer

Bulletin Du Cancer is a scientific journal, published by Elsevier since 1966 in French. The journal's country of origin is France and its primary focus area is oncology.

Details
Abbr. Bull Cancer
Publisher Elsevier
Start 1966
End Continuing
Frequency Monthly, 1990-
p-ISSN 0007-4551
e-ISSN 1769-6917
Country France
Language French
Specialty Oncology
Metrics
h-index / Ranks: 8115 44
SJR / Ranks: 11732 309
CiteScore / Ranks: 10462 2.10
JIF / Ranks: 6553 1.2
Recent Articles
11.
Boudou-Rouquette P, Claude L, Larousserie F, Gouin F, Gaspar N
Bull Cancer . 2025 Mar; PMID: 40058982
No abstract available.
12.
Orbach D, Gandemer V, Pellier I
Bull Cancer . 2025 Mar; PMID: 40057425
No abstract available.
13.
Wankpo B, Angenieux O, Ferrand A, Megy G, Coulaud X, Nacher M, et al.
Bull Cancer . 2025 Mar; PMID: 40055070
Introduction: West Guiana is characterized by a precarious, poor, dispersed population, exposed to infectious and chemical factors. Prostate cancer is the leading cancer in terms of incidence in men. We...
14.
Coste A, Renaud L
Bull Cancer . 2025 Mar; PMID: 40050189
No abstract available.
15.
Maudot C, Koual M, Azais H, Benoit L, Bentivegna E, Nguyen-Xuan H, et al.
Bull Cancer . 2025 Mar; 112(3):326-334. PMID: 40049800
Endometrial cancer is the 4th most common cancer in women in France, with an increasing incidence partly due to the increase in diabetes and obesity. A genetic predisposition is found...
16.
Fidlers T, Narducci F, Pasquesoone C, Hudry D, Mailliez A, Becourt S, et al.
Bull Cancer . 2025 Mar; 112(3):316-325. PMID: 40049799
Risk reducing salpingo-oophorectomy has long been the gold standard for preventing the development of tubo-ovarian cancers in high-risk population such as BRCA1/2 mutation carriers. Although a clear survival benefit has...
17.
Favier A, Evrevin C, Desseignes C, Benusiglio P, Uzan C
Bull Cancer . 2025 Mar; 112(3):307-315. PMID: 40049798
Currently, the main means of diagnosing ovarian cancer at an early stage involve risk prediction, prevention and screening in patients identified as being at genetic risk. Our aim is to...
18.
Michot A, Adam D, Fournier M, Charitansky H, Auriol S, Vinel A, et al.
Bull Cancer . 2025 Mar; 112(3):300-306. PMID: 40049797
In France, breast cancer is the most common cancer among women, with 5 to 10% of cases being genetic. Frequently involved genes include BRCA1 and BRCA2, PALB2, TP53, CDH1, and...
19.
Veziant J, Routier B, Piessen G
Bull Cancer . 2025 Mar; 112(3):277-285. PMID: 40049796
The prognosis for esophageal cancer remains poor because it is often diagnosed late and patients often have unfavourable backgrounds. This is reflected in standardised 5-year net survival rates of no...
20.
Desolneux G, Castanet F
Bull Cancer . 2025 Mar; 112(3):263-269. PMID: 40049795
Pancreatic cancer is a serious pathology whose incidence is increasing. Advances in imaging have made it possible to fortuitously highlight more and more cystic pancreatic lesions, some of which have...